The conversation discusses future hairlosstreatments, with mentions of dutasteride potentially gaining FDA approval and increased popularity. Skepticism remains about significant advancements due to limited funding and reliance on cosmetic companies.
Clascoterone 5% and PP405 are being discussed as potential future treatments for hairloss, with clascoterone nearing phase three completion and PP405 possibly taking a cosmetic route to market. Current treatments like minoxidil, finasteride, and RU58841 are mentioned as effective in slowing hairloss, but a complete cure remains elusive.
Hairloss impacts mental health and should be covered by healthcare, with treatments like finasteride, dutasteride, and minoxidil being affordable and effective. Some argue hairloss is cosmetic and shouldn't be funded, while others highlight its broader health implications.
The conversation is about obtaining pyrilutamide for hairlosstreatment from China through a contact, with details on pricing and shipping. The user offers to facilitate the purchase and shipment for a small commission.